Penile squamous cell carcinoma
Also known as: Squamous Cell Carcinoma (SCC) of the Penis / Penile Squamous Cell Carcinoma (PSCC) / Squamous Cell Penile Carcinoma / Squamous Cell Carcinoma of the Penis / Squamous cell carcinoma of penis (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB00544 | Fluorouracil | 1 / 2 | Recruiting | 1 |
| DB00650 | Leucovorin | 1 / 2 | Recruiting | 1 |
| DB11793 | Niraparib | 1 / 2 | Recruiting | 1 |
| DB16186 | PEN-866 | 1 / 2 | Recruiting | 1 |
| DB08916 | Afatinib | 2 | Terminated | 1 |
| DB11595 | Atezolizumab | 2 | Not Yet Recruiting | 1 |
| DB11945 | Avelumab | 2 | Recruiting | 1 |
| DB08875 | Cabozantinib | 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Not Yet Recruiting | 1 |
| DB00002 | Cetuximab | 2 | Withdrawn | 1 |
| DB00515 | Cisplatin | 2 | Withdrawn | 1 |
| DB01181 | Ifosfamide | 2 | Withdrawn | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Not Yet Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Withdrawn | 1 |
| DB09037 | Pembrolizumab | 2 | Not Yet Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Terminated | 1 |
| DB12146 | Rigosertib | 2 | Completed | 1 |
| DB12893 | Sacituzumab govitecan | 2 | Not Yet Recruiting | 1 |